Global Trade Solutions sectoral insights series – Health & Pharmaceutical

Hong Kong is cementing its role as a global hub for healthcare and pharmaceutical trade, offering a strategic platform for international growth. In 2024, healthcare products made up one-tenth of Hong Kong's domestic exports, exceeding HKD6 billion in value. With initiatives like the Innovation and Technology Fund and a world-class financial ecosystem, the city is attracting enterprises focused on innovation, expansion, and treasury management.

• The HKSAR government’s Innovation and Technology Fund drives R&D, attracting Mainland China enterprises to use Hong Kong SAR as a platform for overseas expansion.
• Hong Kong’s advanced financial ecosystem and its role in RMB internationalisation help businesses establish treasury hubs and expand globally.

At HSBC, we support this dynamic sector with tailored Global Trade Solutions. From optimising capital to mitigating risks in overseas sales, we help healthcare businesses seize global opportunities and navigate complex trade flows with confidence.

• HSBC’s Global Trade Solutions support healthcare and pharmaceutical businesses.
• Key Solutions:
  • Guarantee / Standby DC: Facilitate overseas expansion/tenders and optimise capital by replacing cash deposits with Guarantees/Standby DCs.
  • Working Capital Optimisation: Liquidity injection with buyer credit risk management, offering balance sheet optimisation, subject to auditor opinion, for a robust financial strategy.
  • Structured Trade Solution: Tailored solutions extending beyond sales and procurement to support R&D initiatives.